Global Radionuclide Drug Conjugates Rdc Market Research Report 2026(Status and Outlook)
RDC therapy combines radionuclides with specific monoclonal antibodies to achieve the dual advantages of precise targeting and powerful killing of tumor cells. It can highly concentrate the energy released by radionuclides within several times the diameter of cancer cells, thereby minimizing damage to surrounding normal tissues. This enables it to effectively kill cancer cells while protecting normal tissues, so it has good curative effect and low adverse reactions, and can prolong the survival of patients with advanced cancer, which is of great significance to the treatment of advanced tumors.
The global Radionuclide Drug Conjugates Rdc market size was estimated at USD 2450.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Radionuclide Drug Conjugates Rdc market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Radionuclide Drug Conjugates Rdc market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Radionuclide Drug Conjugates Rdc market.
Global Radionuclide Drug Conjugates Rdc Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
POINT Biopharma
Telix
ITM AG
Bayer AG
Novartis
Lantheus
Curium Pharma
Uihc Pet Imaging
Grand Pharma
BoomRay Pharmaceuticals
SmartNuclide Biopharma
Hengrui Medicine
Yunnan Baiyao Group
Sinotau
Hexin Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Market Segmentation (by Type)
Antibody Radionuclide Conjugates (ARC)
Peptide Radionuclide Conjugates (PRC)
Small Molecular Radionuclide Conjugates (SMRC)
Market Segmentation (by Application)
Neuroendocrine Tumors
Prostate Cancer
Renal Cell Carcinoma
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radionuclide Drug Conjugates Rdc Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radionuclide Drug Conjugates Rdc, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Radionuclide Drug Conjugates Rdc market size was estimated at USD 2450.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 12.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Radionuclide Drug Conjugates Rdc market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Radionuclide Drug Conjugates Rdc market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Radionuclide Drug Conjugates Rdc market.
Global Radionuclide Drug Conjugates Rdc Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
POINT Biopharma
Telix
ITM AG
Bayer AG
Novartis
Lantheus
Curium Pharma
Uihc Pet Imaging
Grand Pharma
BoomRay Pharmaceuticals
SmartNuclide Biopharma
Hengrui Medicine
Yunnan Baiyao Group
Sinotau
Hexin Pharmaceutical
Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
Market Segmentation (by Type)
Antibody Radionuclide Conjugates (ARC)
Peptide Radionuclide Conjugates (PRC)
Small Molecular Radionuclide Conjugates (SMRC)
Market Segmentation (by Application)
Neuroendocrine Tumors
Prostate Cancer
Renal Cell Carcinoma
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Radionuclide Drug Conjugates Rdc Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radionuclide Drug Conjugates Rdc Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Radionuclide Drug Conjugates Rdc, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radionuclide Drug Conjugates Rdc
1.2 Key Market Segments
1.2.1 Radionuclide Drug Conjugates Rdc Segment by Type
1.2.2 Radionuclide Drug Conjugates Rdc Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIONUCLIDE DRUG CONJUGATES RDC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radionuclide Drug Conjugates Rdc Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Radionuclide Drug Conjugates Rdc Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIONUCLIDE DRUG CONJUGATES RDC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radionuclide Drug Conjugates Rdc Product Life Cycle
3.3 Global Radionuclide Drug Conjugates Rdc Sales by Manufacturers (2020-2025)
3.4 Global Radionuclide Drug Conjugates Rdc Revenue Market Share by Manufacturers (2020-2025)
3.5 Radionuclide Drug Conjugates Rdc Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radionuclide Drug Conjugates Rdc Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Radionuclide Drug Conjugates Rdc Market Competitive Situation and Trends
3.8.1 Radionuclide Drug Conjugates Rdc Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radionuclide Drug Conjugates Rdc Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIONUCLIDE DRUG CONJUGATES RDC INDUSTRY CHAIN ANALYSIS
4.1 Radionuclide Drug Conjugates Rdc Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIONUCLIDE DRUG CONJUGATES RDC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radionuclide Drug Conjugates Rdc Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radionuclide Drug Conjugates Rdc Market
5.7 ESG Ratings of Leading Companies
6 RADIONUCLIDE DRUG CONJUGATES RDC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radionuclide Drug Conjugates Rdc Sales Market Share by Type (2020-2025)
6.3 Global Radionuclide Drug Conjugates Rdc Market Size by Type (2020-2025)
6.4 Global Radionuclide Drug Conjugates Rdc Price by Type (2020-2025)
7 RADIONUCLIDE DRUG CONJUGATES RDC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radionuclide Drug Conjugates Rdc Market Sales by Application (2020-2025)
7.3 Global Radionuclide Drug Conjugates Rdc Market Size (M USD) by Application (2020-2025)
7.4 Global Radionuclide Drug Conjugates Rdc Sales Growth Rate by Application (2020-2025)
8 RADIONUCLIDE DRUG CONJUGATES RDC MARKET SALES BY REGION
8.1 Global Radionuclide Drug Conjugates Rdc Sales by Region
8.1.1 Global Radionuclide Drug Conjugates Rdc Sales by Region
8.1.2 Global Radionuclide Drug Conjugates Rdc Sales Market Share by Region
8.2 Global Radionuclide Drug Conjugates Rdc Market Size by Region
8.2.1 Global Radionuclide Drug Conjugates Rdc Market Size by Region
8.2.2 Global Radionuclide Drug Conjugates Rdc Market Size by Region
8.3 North America
8.3.1 North America Radionuclide Drug Conjugates Rdc Sales by Country
8.3.2 North America Radionuclide Drug Conjugates Rdc Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radionuclide Drug Conjugates Rdc Sales by Country
8.4.2 Europe Radionuclide Drug Conjugates Rdc Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radionuclide Drug Conjugates Rdc Sales by Region
8.5.2 Asia Pacific Radionuclide Drug Conjugates Rdc Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radionuclide Drug Conjugates Rdc Sales by Country
8.6.2 South America Radionuclide Drug Conjugates Rdc Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radionuclide Drug Conjugates Rdc Sales by Region
8.7.2 Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIONUCLIDE DRUG CONJUGATES RDC MARKET PRODUCTION BY REGION
9.1 Global Production of Radionuclide Drug Conjugates Rdc by Region(2020-2025)
9.2 Global Radionuclide Drug Conjugates Rdc Revenue Market Share by Region (2020-2025)
9.3 Global Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radionuclide Drug Conjugates Rdc Production
9.4.1 North America Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.4.2 North America Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radionuclide Drug Conjugates Rdc Production
9.5.1 Europe Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.5.2 Europe Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radionuclide Drug Conjugates Rdc Production (2020-2025)
9.6.1 Japan Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.6.2 Japan Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radionuclide Drug Conjugates Rdc Production (2020-2025)
9.7.1 China Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.7.2 China Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 POINT Biopharma
10.1.1 POINT Biopharma Basic Information
10.1.2 POINT Biopharma Radionuclide Drug Conjugates Rdc Product Overview
10.1.3 POINT Biopharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.1.4 POINT Biopharma Business Overview
10.1.5 POINT Biopharma SWOT Analysis
10.1.6 POINT Biopharma Recent Developments
10.2 Telix
10.2.1 Telix Basic Information
10.2.2 Telix Radionuclide Drug Conjugates Rdc Product Overview
10.2.3 Telix Radionuclide Drug Conjugates Rdc Product Market Performance
10.2.4 Telix Business Overview
10.2.5 Telix SWOT Analysis
10.2.6 Telix Recent Developments
10.3 ITM AG
10.3.1 ITM AG Basic Information
10.3.2 ITM AG Radionuclide Drug Conjugates Rdc Product Overview
10.3.3 ITM AG Radionuclide Drug Conjugates Rdc Product Market Performance
10.3.4 ITM AG Business Overview
10.3.5 ITM AG SWOT Analysis
10.3.6 ITM AG Recent Developments
10.4 Bayer AG
10.4.1 Bayer AG Basic Information
10.4.2 Bayer AG Radionuclide Drug Conjugates Rdc Product Overview
10.4.3 Bayer AG Radionuclide Drug Conjugates Rdc Product Market Performance
10.4.4 Bayer AG Business Overview
10.4.5 Bayer AG Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Radionuclide Drug Conjugates Rdc Product Overview
10.5.3 Novartis Radionuclide Drug Conjugates Rdc Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Lantheus
10.6.1 Lantheus Basic Information
10.6.2 Lantheus Radionuclide Drug Conjugates Rdc Product Overview
10.6.3 Lantheus Radionuclide Drug Conjugates Rdc Product Market Performance
10.6.4 Lantheus Business Overview
10.6.5 Lantheus Recent Developments
10.7 Curium Pharma
10.7.1 Curium Pharma Basic Information
10.7.2 Curium Pharma Radionuclide Drug Conjugates Rdc Product Overview
10.7.3 Curium Pharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.7.4 Curium Pharma Business Overview
10.7.5 Curium Pharma Recent Developments
10.8 Uihc Pet Imaging
10.8.1 Uihc Pet Imaging Basic Information
10.8.2 Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Product Overview
10.8.3 Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Product Market Performance
10.8.4 Uihc Pet Imaging Business Overview
10.8.5 Uihc Pet Imaging Recent Developments
10.9 Grand Pharma
10.9.1 Grand Pharma Basic Information
10.9.2 Grand Pharma Radionuclide Drug Conjugates Rdc Product Overview
10.9.3 Grand Pharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.9.4 Grand Pharma Business Overview
10.9.5 Grand Pharma Recent Developments
10.10 BoomRay Pharmaceuticals
10.10.1 BoomRay Pharmaceuticals Basic Information
10.10.2 BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Product Overview
10.10.3 BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Product Market Performance
10.10.4 BoomRay Pharmaceuticals Business Overview
10.10.5 BoomRay Pharmaceuticals Recent Developments
10.11 SmartNuclide Biopharma
10.11.1 SmartNuclide Biopharma Basic Information
10.11.2 SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Product Overview
10.11.3 SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.11.4 SmartNuclide Biopharma Business Overview
10.11.5 SmartNuclide Biopharma Recent Developments
10.12 Hengrui Medicine
10.12.1 Hengrui Medicine Basic Information
10.12.2 Hengrui Medicine Radionuclide Drug Conjugates Rdc Product Overview
10.12.3 Hengrui Medicine Radionuclide Drug Conjugates Rdc Product Market Performance
10.12.4 Hengrui Medicine Business Overview
10.12.5 Hengrui Medicine Recent Developments
10.13 Yunnan Baiyao Group
10.13.1 Yunnan Baiyao Group Basic Information
10.13.2 Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Product Overview
10.13.3 Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Product Market Performance
10.13.4 Yunnan Baiyao Group Business Overview
10.13.5 Yunnan Baiyao Group Recent Developments
10.14 Sinotau
10.14.1 Sinotau Basic Information
10.14.2 Sinotau Radionuclide Drug Conjugates Rdc Product Overview
10.14.3 Sinotau Radionuclide Drug Conjugates Rdc Product Market Performance
10.14.4 Sinotau Business Overview
10.14.5 Sinotau Recent Developments
10.15 Hexin Pharmaceutical
10.15.1 Hexin Pharmaceutical Basic Information
10.15.2 Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Product Overview
10.15.3 Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Product Market Performance
10.15.4 Hexin Pharmaceutical Business Overview
10.15.5 Hexin Pharmaceutical Recent Developments
10.16 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
10.16.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Basic Information
10.16.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Product Overview
10.16.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Product Market Performance
10.16.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
10.16.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
11 RADIONUCLIDE DRUG CONJUGATES RDC MARKET FORECAST BY REGION
11.1 Global Radionuclide Drug Conjugates Rdc Market Size Forecast
11.2 Global Radionuclide Drug Conjugates Rdc Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radionuclide Drug Conjugates Rdc Market Size Forecast by Country
11.2.3 Asia Pacific Radionuclide Drug Conjugates Rdc Market Size Forecast by Region
11.2.4 South America Radionuclide Drug Conjugates Rdc Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radionuclide Drug Conjugates Rdc by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Radionuclide Drug Conjugates Rdc Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Radionuclide Drug Conjugates Rdc by Type (2026-2035)
12.1.2 Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Radionuclide Drug Conjugates Rdc by Type (2026-2035)
12.2 Global Radionuclide Drug Conjugates Rdc Market Forecast by Application (2026-2035)
12.2.1 Global Radionuclide Drug Conjugates Rdc Sales (K Units) Forecast by Application
12.2.2 Global Radionuclide Drug Conjugates Rdc Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radionuclide Drug Conjugates Rdc
1.2 Key Market Segments
1.2.1 Radionuclide Drug Conjugates Rdc Segment by Type
1.2.2 Radionuclide Drug Conjugates Rdc Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIONUCLIDE DRUG CONJUGATES RDC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radionuclide Drug Conjugates Rdc Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Radionuclide Drug Conjugates Rdc Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIONUCLIDE DRUG CONJUGATES RDC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Radionuclide Drug Conjugates Rdc Product Life Cycle
3.3 Global Radionuclide Drug Conjugates Rdc Sales by Manufacturers (2020-2025)
3.4 Global Radionuclide Drug Conjugates Rdc Revenue Market Share by Manufacturers (2020-2025)
3.5 Radionuclide Drug Conjugates Rdc Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Radionuclide Drug Conjugates Rdc Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Radionuclide Drug Conjugates Rdc Market Competitive Situation and Trends
3.8.1 Radionuclide Drug Conjugates Rdc Market Concentration Rate
3.8.2 Global 5 and 10 Largest Radionuclide Drug Conjugates Rdc Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 RADIONUCLIDE DRUG CONJUGATES RDC INDUSTRY CHAIN ANALYSIS
4.1 Radionuclide Drug Conjugates Rdc Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIONUCLIDE DRUG CONJUGATES RDC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Radionuclide Drug Conjugates Rdc Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Radionuclide Drug Conjugates Rdc Market
5.7 ESG Ratings of Leading Companies
6 RADIONUCLIDE DRUG CONJUGATES RDC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radionuclide Drug Conjugates Rdc Sales Market Share by Type (2020-2025)
6.3 Global Radionuclide Drug Conjugates Rdc Market Size by Type (2020-2025)
6.4 Global Radionuclide Drug Conjugates Rdc Price by Type (2020-2025)
7 RADIONUCLIDE DRUG CONJUGATES RDC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radionuclide Drug Conjugates Rdc Market Sales by Application (2020-2025)
7.3 Global Radionuclide Drug Conjugates Rdc Market Size (M USD) by Application (2020-2025)
7.4 Global Radionuclide Drug Conjugates Rdc Sales Growth Rate by Application (2020-2025)
8 RADIONUCLIDE DRUG CONJUGATES RDC MARKET SALES BY REGION
8.1 Global Radionuclide Drug Conjugates Rdc Sales by Region
8.1.1 Global Radionuclide Drug Conjugates Rdc Sales by Region
8.1.2 Global Radionuclide Drug Conjugates Rdc Sales Market Share by Region
8.2 Global Radionuclide Drug Conjugates Rdc Market Size by Region
8.2.1 Global Radionuclide Drug Conjugates Rdc Market Size by Region
8.2.2 Global Radionuclide Drug Conjugates Rdc Market Size by Region
8.3 North America
8.3.1 North America Radionuclide Drug Conjugates Rdc Sales by Country
8.3.2 North America Radionuclide Drug Conjugates Rdc Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Radionuclide Drug Conjugates Rdc Sales by Country
8.4.2 Europe Radionuclide Drug Conjugates Rdc Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Radionuclide Drug Conjugates Rdc Sales by Region
8.5.2 Asia Pacific Radionuclide Drug Conjugates Rdc Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Radionuclide Drug Conjugates Rdc Sales by Country
8.6.2 South America Radionuclide Drug Conjugates Rdc Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Radionuclide Drug Conjugates Rdc Sales by Region
8.7.2 Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 RADIONUCLIDE DRUG CONJUGATES RDC MARKET PRODUCTION BY REGION
9.1 Global Production of Radionuclide Drug Conjugates Rdc by Region(2020-2025)
9.2 Global Radionuclide Drug Conjugates Rdc Revenue Market Share by Region (2020-2025)
9.3 Global Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Radionuclide Drug Conjugates Rdc Production
9.4.1 North America Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.4.2 North America Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Radionuclide Drug Conjugates Rdc Production
9.5.1 Europe Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.5.2 Europe Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Radionuclide Drug Conjugates Rdc Production (2020-2025)
9.6.1 Japan Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.6.2 Japan Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Radionuclide Drug Conjugates Rdc Production (2020-2025)
9.7.1 China Radionuclide Drug Conjugates Rdc Production Growth Rate (2020-2025)
9.7.2 China Radionuclide Drug Conjugates Rdc Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 POINT Biopharma
10.1.1 POINT Biopharma Basic Information
10.1.2 POINT Biopharma Radionuclide Drug Conjugates Rdc Product Overview
10.1.3 POINT Biopharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.1.4 POINT Biopharma Business Overview
10.1.5 POINT Biopharma SWOT Analysis
10.1.6 POINT Biopharma Recent Developments
10.2 Telix
10.2.1 Telix Basic Information
10.2.2 Telix Radionuclide Drug Conjugates Rdc Product Overview
10.2.3 Telix Radionuclide Drug Conjugates Rdc Product Market Performance
10.2.4 Telix Business Overview
10.2.5 Telix SWOT Analysis
10.2.6 Telix Recent Developments
10.3 ITM AG
10.3.1 ITM AG Basic Information
10.3.2 ITM AG Radionuclide Drug Conjugates Rdc Product Overview
10.3.3 ITM AG Radionuclide Drug Conjugates Rdc Product Market Performance
10.3.4 ITM AG Business Overview
10.3.5 ITM AG SWOT Analysis
10.3.6 ITM AG Recent Developments
10.4 Bayer AG
10.4.1 Bayer AG Basic Information
10.4.2 Bayer AG Radionuclide Drug Conjugates Rdc Product Overview
10.4.3 Bayer AG Radionuclide Drug Conjugates Rdc Product Market Performance
10.4.4 Bayer AG Business Overview
10.4.5 Bayer AG Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis Radionuclide Drug Conjugates Rdc Product Overview
10.5.3 Novartis Radionuclide Drug Conjugates Rdc Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Lantheus
10.6.1 Lantheus Basic Information
10.6.2 Lantheus Radionuclide Drug Conjugates Rdc Product Overview
10.6.3 Lantheus Radionuclide Drug Conjugates Rdc Product Market Performance
10.6.4 Lantheus Business Overview
10.6.5 Lantheus Recent Developments
10.7 Curium Pharma
10.7.1 Curium Pharma Basic Information
10.7.2 Curium Pharma Radionuclide Drug Conjugates Rdc Product Overview
10.7.3 Curium Pharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.7.4 Curium Pharma Business Overview
10.7.5 Curium Pharma Recent Developments
10.8 Uihc Pet Imaging
10.8.1 Uihc Pet Imaging Basic Information
10.8.2 Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Product Overview
10.8.3 Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Product Market Performance
10.8.4 Uihc Pet Imaging Business Overview
10.8.5 Uihc Pet Imaging Recent Developments
10.9 Grand Pharma
10.9.1 Grand Pharma Basic Information
10.9.2 Grand Pharma Radionuclide Drug Conjugates Rdc Product Overview
10.9.3 Grand Pharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.9.4 Grand Pharma Business Overview
10.9.5 Grand Pharma Recent Developments
10.10 BoomRay Pharmaceuticals
10.10.1 BoomRay Pharmaceuticals Basic Information
10.10.2 BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Product Overview
10.10.3 BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Product Market Performance
10.10.4 BoomRay Pharmaceuticals Business Overview
10.10.5 BoomRay Pharmaceuticals Recent Developments
10.11 SmartNuclide Biopharma
10.11.1 SmartNuclide Biopharma Basic Information
10.11.2 SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Product Overview
10.11.3 SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Product Market Performance
10.11.4 SmartNuclide Biopharma Business Overview
10.11.5 SmartNuclide Biopharma Recent Developments
10.12 Hengrui Medicine
10.12.1 Hengrui Medicine Basic Information
10.12.2 Hengrui Medicine Radionuclide Drug Conjugates Rdc Product Overview
10.12.3 Hengrui Medicine Radionuclide Drug Conjugates Rdc Product Market Performance
10.12.4 Hengrui Medicine Business Overview
10.12.5 Hengrui Medicine Recent Developments
10.13 Yunnan Baiyao Group
10.13.1 Yunnan Baiyao Group Basic Information
10.13.2 Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Product Overview
10.13.3 Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Product Market Performance
10.13.4 Yunnan Baiyao Group Business Overview
10.13.5 Yunnan Baiyao Group Recent Developments
10.14 Sinotau
10.14.1 Sinotau Basic Information
10.14.2 Sinotau Radionuclide Drug Conjugates Rdc Product Overview
10.14.3 Sinotau Radionuclide Drug Conjugates Rdc Product Market Performance
10.14.4 Sinotau Business Overview
10.14.5 Sinotau Recent Developments
10.15 Hexin Pharmaceutical
10.15.1 Hexin Pharmaceutical Basic Information
10.15.2 Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Product Overview
10.15.3 Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Product Market Performance
10.15.4 Hexin Pharmaceutical Business Overview
10.15.5 Hexin Pharmaceutical Recent Developments
10.16 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd.
10.16.1 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Basic Information
10.16.2 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Product Overview
10.16.3 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Product Market Performance
10.16.4 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
10.16.5 Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
11 RADIONUCLIDE DRUG CONJUGATES RDC MARKET FORECAST BY REGION
11.1 Global Radionuclide Drug Conjugates Rdc Market Size Forecast
11.2 Global Radionuclide Drug Conjugates Rdc Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Radionuclide Drug Conjugates Rdc Market Size Forecast by Country
11.2.3 Asia Pacific Radionuclide Drug Conjugates Rdc Market Size Forecast by Region
11.2.4 South America Radionuclide Drug Conjugates Rdc Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Radionuclide Drug Conjugates Rdc by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Radionuclide Drug Conjugates Rdc Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Radionuclide Drug Conjugates Rdc by Type (2026-2035)
12.1.2 Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Radionuclide Drug Conjugates Rdc by Type (2026-2035)
12.2 Global Radionuclide Drug Conjugates Rdc Market Forecast by Application (2026-2035)
12.2.1 Global Radionuclide Drug Conjugates Rdc Sales (K Units) Forecast by Application
12.2.2 Global Radionuclide Drug Conjugates Rdc Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radionuclide Drug Conjugates Rdc Market Size by Type (M USD)
Table 4. Global Radionuclide Drug Conjugates Rdc Market Size by Application
Table 5. Radionuclide Drug Conjugates Rdc Market Size Comparison by Region (M USD)
Table 6. Global Radionuclide Drug Conjugates Rdc Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radionuclide Drug Conjugates Rdc Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radionuclide Drug Conjugates Rdc Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radionuclide Drug Conjugates Rdc as of 2025)
Table 11. Global Market Radionuclide Drug Conjugates Rdc Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Radionuclide Drug Conjugates Rdc Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radionuclide Drug Conjugates Rdc Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Radionuclide Drug Conjugates Rdc Sales by Type (K Units)
Table 27. Global Radionuclide Drug Conjugates Rdc Market Size by Type (M USD)
Table 28. Global Radionuclide Drug Conjugates Rdc Sales (K Units) by Type (2020-2025)
Table 29. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Type (2020-2025)
Table 30. Global Radionuclide Drug Conjugates Rdc Market Size (M USD) by Type (2020-2025)
Table 31. Global Radionuclide Drug Conjugates Rdc Market Share by Type (2020-2025)
Table 32. Global Radionuclide Drug Conjugates Rdc Price (USD/Unit) by Type (2020-2025)
Table 33. Global Radionuclide Drug Conjugates Rdc Sales (K Units) by Application
Table 34. Global Radionuclide Drug Conjugates Rdc Market Size by Application
Table 35. Global Radionuclide Drug Conjugates Rdc Sales by Application (2020-2025) & (K Units)
Table 36. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Application (2020-2025)
Table 37. Global Radionuclide Drug Conjugates Rdc Market Size by Application (2020-2025) & (M USD)
Table 38. Global Radionuclide Drug Conjugates Rdc Market Share by Application (2020-2025)
Table 39. Global Radionuclide Drug Conjugates Rdc Sales Growth Rate by Application (2020-2025)
Table 40. Global Radionuclide Drug Conjugates Rdc Sales by Region (2020-2025) & (K Units)
Table 41. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Region (2020-2025)
Table 42. Global Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025) & (M USD)
Table 43. Global Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025)
Table 44. North America Radionuclide Drug Conjugates Rdc Sales by Country (2020-2025) & (K Units)
Table 45. North America Radionuclide Drug Conjugates Rdc Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Radionuclide Drug Conjugates Rdc Sales by Country (2020-2025) & (K Units)
Table 47. Europe Radionuclide Drug Conjugates Rdc Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Radionuclide Drug Conjugates Rdc Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025) & (M USD)
Table 50. South America Radionuclide Drug Conjugates Rdc Sales by Country (2020-2025) & (K Units)
Table 51. South America Radionuclide Drug Conjugates Rdc Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025) & (M USD)
Table 54. Global Radionuclide Drug Conjugates Rdc Production (K Units) by Region(2020-2025)
Table 55. Global Radionuclide Drug Conjugates Rdc Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Radionuclide Drug Conjugates Rdc Revenue Market Share by Region (2020-2025)
Table 57. Global Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. POINT Biopharma Basic Information
Table 63. POINT Biopharma Radionuclide Drug Conjugates Rdc Product Overview
Table 64. POINT Biopharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. POINT Biopharma Business Overview
Table 66. POINT Biopharma SWOT Analysis
Table 67. POINT Biopharma Recent Developments
Table 68. Telix Basic Information
Table 69. Telix Radionuclide Drug Conjugates Rdc Product Overview
Table 70. Telix Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Telix Business Overview
Table 72. Telix SWOT Analysis
Table 73. Telix Recent Developments
Table 74. ITM AG Basic Information
Table 75. ITM AG Radionuclide Drug Conjugates Rdc Product Overview
Table 76. ITM AG Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ITM AG Business Overview
Table 78. ITM AG SWOT Analysis
Table 79. ITM AG Recent Developments
Table 80. Bayer AG Basic Information
Table 81. Bayer AG Radionuclide Drug Conjugates Rdc Product Overview
Table 82. Bayer AG Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis Radionuclide Drug Conjugates Rdc Product Overview
Table 87. Novartis Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Lantheus Basic Information
Table 91. Lantheus Radionuclide Drug Conjugates Rdc Product Overview
Table 92. Lantheus Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Lantheus Business Overview
Table 94. Lantheus Recent Developments
Table 95. Curium Pharma Basic Information
Table 96. Curium Pharma Radionuclide Drug Conjugates Rdc Product Overview
Table 97. Curium Pharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Curium Pharma Business Overview
Table 99. Curium Pharma Recent Developments
Table 100. Uihc Pet Imaging Basic Information
Table 101. Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Product Overview
Table 102. Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Uihc Pet Imaging Business Overview
Table 104. Uihc Pet Imaging Recent Developments
Table 105. Grand Pharma Basic Information
Table 106. Grand Pharma Radionuclide Drug Conjugates Rdc Product Overview
Table 107. Grand Pharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Grand Pharma Business Overview
Table 109. Grand Pharma Recent Developments
Table 110. BoomRay Pharmaceuticals Basic Information
Table 111. BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Product Overview
Table 112. BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. BoomRay Pharmaceuticals Business Overview
Table 114. BoomRay Pharmaceuticals Recent Developments
Table 115. SmartNuclide Biopharma Basic Information
Table 116. SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Product Overview
Table 117. SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. SmartNuclide Biopharma Business Overview
Table 119. SmartNuclide Biopharma Recent Developments
Table 120. Hengrui Medicine Basic Information
Table 121. Hengrui Medicine Radionuclide Drug Conjugates Rdc Product Overview
Table 122. Hengrui Medicine Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Hengrui Medicine Business Overview
Table 124. Hengrui Medicine Recent Developments
Table 125. Yunnan Baiyao Group Basic Information
Table 126. Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Product Overview
Table 127. Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Yunnan Baiyao Group Business Overview
Table 129. Yunnan Baiyao Group Recent Developments
Table 130. Sinotau Basic Information
Table 131. Sinotau Radionuclide Drug Conjugates Rdc Product Overview
Table 132. Sinotau Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sinotau Business Overview
Table 134. Sinotau Recent Developments
Table 135. Hexin Pharmaceutical Basic Information
Table 136. Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Product Overview
Table 137. Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Hexin Pharmaceutical Business Overview
Table 139. Hexin Pharmaceutical Recent Developments
Table 140. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Basic Information
Table 141. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Product Overview
Table 142. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
Table 144. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
Table 145. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Radionuclide Drug Conjugates Rdc Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Radionuclide Drug Conjugates Rdc Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Radionuclide Drug Conjugates Rdc Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Radionuclide Drug Conjugates Rdc Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Radionuclide Drug Conjugates Rdc Market Size by Type (M USD)
Table 4. Global Radionuclide Drug Conjugates Rdc Market Size by Application
Table 5. Radionuclide Drug Conjugates Rdc Market Size Comparison by Region (M USD)
Table 6. Global Radionuclide Drug Conjugates Rdc Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Radionuclide Drug Conjugates Rdc Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Radionuclide Drug Conjugates Rdc Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radionuclide Drug Conjugates Rdc as of 2025)
Table 11. Global Market Radionuclide Drug Conjugates Rdc Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Radionuclide Drug Conjugates Rdc Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radionuclide Drug Conjugates Rdc Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Radionuclide Drug Conjugates Rdc Sales by Type (K Units)
Table 27. Global Radionuclide Drug Conjugates Rdc Market Size by Type (M USD)
Table 28. Global Radionuclide Drug Conjugates Rdc Sales (K Units) by Type (2020-2025)
Table 29. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Type (2020-2025)
Table 30. Global Radionuclide Drug Conjugates Rdc Market Size (M USD) by Type (2020-2025)
Table 31. Global Radionuclide Drug Conjugates Rdc Market Share by Type (2020-2025)
Table 32. Global Radionuclide Drug Conjugates Rdc Price (USD/Unit) by Type (2020-2025)
Table 33. Global Radionuclide Drug Conjugates Rdc Sales (K Units) by Application
Table 34. Global Radionuclide Drug Conjugates Rdc Market Size by Application
Table 35. Global Radionuclide Drug Conjugates Rdc Sales by Application (2020-2025) & (K Units)
Table 36. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Application (2020-2025)
Table 37. Global Radionuclide Drug Conjugates Rdc Market Size by Application (2020-2025) & (M USD)
Table 38. Global Radionuclide Drug Conjugates Rdc Market Share by Application (2020-2025)
Table 39. Global Radionuclide Drug Conjugates Rdc Sales Growth Rate by Application (2020-2025)
Table 40. Global Radionuclide Drug Conjugates Rdc Sales by Region (2020-2025) & (K Units)
Table 41. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Region (2020-2025)
Table 42. Global Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025) & (M USD)
Table 43. Global Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025)
Table 44. North America Radionuclide Drug Conjugates Rdc Sales by Country (2020-2025) & (K Units)
Table 45. North America Radionuclide Drug Conjugates Rdc Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Radionuclide Drug Conjugates Rdc Sales by Country (2020-2025) & (K Units)
Table 47. Europe Radionuclide Drug Conjugates Rdc Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Radionuclide Drug Conjugates Rdc Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025) & (M USD)
Table 50. South America Radionuclide Drug Conjugates Rdc Sales by Country (2020-2025) & (K Units)
Table 51. South America Radionuclide Drug Conjugates Rdc Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025) & (M USD)
Table 54. Global Radionuclide Drug Conjugates Rdc Production (K Units) by Region(2020-2025)
Table 55. Global Radionuclide Drug Conjugates Rdc Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Radionuclide Drug Conjugates Rdc Revenue Market Share by Region (2020-2025)
Table 57. Global Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Radionuclide Drug Conjugates Rdc Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. POINT Biopharma Basic Information
Table 63. POINT Biopharma Radionuclide Drug Conjugates Rdc Product Overview
Table 64. POINT Biopharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. POINT Biopharma Business Overview
Table 66. POINT Biopharma SWOT Analysis
Table 67. POINT Biopharma Recent Developments
Table 68. Telix Basic Information
Table 69. Telix Radionuclide Drug Conjugates Rdc Product Overview
Table 70. Telix Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Telix Business Overview
Table 72. Telix SWOT Analysis
Table 73. Telix Recent Developments
Table 74. ITM AG Basic Information
Table 75. ITM AG Radionuclide Drug Conjugates Rdc Product Overview
Table 76. ITM AG Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. ITM AG Business Overview
Table 78. ITM AG SWOT Analysis
Table 79. ITM AG Recent Developments
Table 80. Bayer AG Basic Information
Table 81. Bayer AG Radionuclide Drug Conjugates Rdc Product Overview
Table 82. Bayer AG Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Bayer AG Business Overview
Table 84. Bayer AG Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis Radionuclide Drug Conjugates Rdc Product Overview
Table 87. Novartis Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Lantheus Basic Information
Table 91. Lantheus Radionuclide Drug Conjugates Rdc Product Overview
Table 92. Lantheus Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Lantheus Business Overview
Table 94. Lantheus Recent Developments
Table 95. Curium Pharma Basic Information
Table 96. Curium Pharma Radionuclide Drug Conjugates Rdc Product Overview
Table 97. Curium Pharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Curium Pharma Business Overview
Table 99. Curium Pharma Recent Developments
Table 100. Uihc Pet Imaging Basic Information
Table 101. Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Product Overview
Table 102. Uihc Pet Imaging Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Uihc Pet Imaging Business Overview
Table 104. Uihc Pet Imaging Recent Developments
Table 105. Grand Pharma Basic Information
Table 106. Grand Pharma Radionuclide Drug Conjugates Rdc Product Overview
Table 107. Grand Pharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Grand Pharma Business Overview
Table 109. Grand Pharma Recent Developments
Table 110. BoomRay Pharmaceuticals Basic Information
Table 111. BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Product Overview
Table 112. BoomRay Pharmaceuticals Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. BoomRay Pharmaceuticals Business Overview
Table 114. BoomRay Pharmaceuticals Recent Developments
Table 115. SmartNuclide Biopharma Basic Information
Table 116. SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Product Overview
Table 117. SmartNuclide Biopharma Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. SmartNuclide Biopharma Business Overview
Table 119. SmartNuclide Biopharma Recent Developments
Table 120. Hengrui Medicine Basic Information
Table 121. Hengrui Medicine Radionuclide Drug Conjugates Rdc Product Overview
Table 122. Hengrui Medicine Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Hengrui Medicine Business Overview
Table 124. Hengrui Medicine Recent Developments
Table 125. Yunnan Baiyao Group Basic Information
Table 126. Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Product Overview
Table 127. Yunnan Baiyao Group Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Yunnan Baiyao Group Business Overview
Table 129. Yunnan Baiyao Group Recent Developments
Table 130. Sinotau Basic Information
Table 131. Sinotau Radionuclide Drug Conjugates Rdc Product Overview
Table 132. Sinotau Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Sinotau Business Overview
Table 134. Sinotau Recent Developments
Table 135. Hexin Pharmaceutical Basic Information
Table 136. Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Product Overview
Table 137. Hexin Pharmaceutical Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Hexin Pharmaceutical Business Overview
Table 139. Hexin Pharmaceutical Recent Developments
Table 140. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Basic Information
Table 141. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Product Overview
Table 142. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Radionuclide Drug Conjugates Rdc Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Business Overview
Table 144. Shenzhen Jianyuan Pharmaceutical Technology Co., Ltd. Recent Developments
Table 145. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Region (2026-2035) & (K Units)
Table 146. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Region (2026-2035) & (M USD)
Table 147. North America Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (K Units)
Table 148. North America Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 149. Europe Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (K Units)
Table 150. Europe Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 151. Asia Pacific Radionuclide Drug Conjugates Rdc Sales Forecast by Region (2026-2035) & (K Units)
Table 152. Asia Pacific Radionuclide Drug Conjugates Rdc Market Size Forecast by Region (2026-2035) & (M USD)
Table 153. South America Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (K Units)
Table 154. South America Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 155. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales Forecast by Country (2026-2035) & (Units)
Table 156. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size Forecast by Country (2026-2035) & (M USD)
Table 157. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Type (2026-2035) & (K Units)
Table 158. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Type (2026-2035) & (M USD)
Table 159. Global Radionuclide Drug Conjugates Rdc Price Forecast by Type (2026-2035) & (USD/Unit)
Table 160. Global Radionuclide Drug Conjugates Rdc Sales (K Units) Forecast by Application (2026-2035)
Table 161. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radionuclide Drug Conjugates Rdc
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radionuclide Drug Conjugates Rdc Market Size (M USD), 2025-2035
Figure 5. Global Radionuclide Drug Conjugates Rdc Market Size (M USD) (2020-2035)
Figure 6. Global Radionuclide Drug Conjugates Rdc Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radionuclide Drug Conjugates Rdc Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radionuclide Drug Conjugates Rdc Product Life Cycle
Figure 13. Radionuclide Drug Conjugates Rdc Sales Share by Manufacturers in 2025
Figure 14. Global Radionuclide Drug Conjugates Rdc Revenue Share by Manufacturers in 2025
Figure 15. Radionuclide Drug Conjugates Rdc Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Radionuclide Drug Conjugates Rdc Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radionuclide Drug Conjugates Rdc Revenue in 2025
Figure 18. Industry Chain Map of Radionuclide Drug Conjugates Rdc
Figure 19. Global Radionuclide Drug Conjugates Rdc Market PEST Analysis
Figure 20. Global Radionuclide Drug Conjugates Rdc Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radionuclide Drug Conjugates Rdc Market Share by Type
Figure 27. Sales Market Share of Radionuclide Drug Conjugates Rdc by Type (2020-2025)
Figure 28. Sales Market Share of Radionuclide Drug Conjugates Rdc by Type in 2025
Figure 29. Market Share of Radionuclide Drug Conjugates Rdc by Type (2020-2025)
Figure 30. Market Share of Radionuclide Drug Conjugates Rdc by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radionuclide Drug Conjugates Rdc Market Share by Application
Figure 33. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Application (2020-2025)
Figure 34. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Application in 2025
Figure 35. Global Radionuclide Drug Conjugates Rdc Market Share by Application (2020-2025)
Figure 36. Global Radionuclide Drug Conjugates Rdc Market Share by Application in 2025
Figure 37. Global Radionuclide Drug Conjugates Rdc Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Region (2020-2025)
Figure 39. Global Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025)
Figure 40. North America Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Radionuclide Drug Conjugates Rdc Sales Market Share by Country in 2024
Figure 43. North America Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radionuclide Drug Conjugates Rdc Market Size by Country in 2024
Figure 45. U.S. Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radionuclide Drug Conjugates Rdc Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Radionuclide Drug Conjugates Rdc Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radionuclide Drug Conjugates Rdc Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radionuclide Drug Conjugates Rdc Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Radionuclide Drug Conjugates Rdc Sales Market Share by Country in 2024
Figure 53. Europe Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radionuclide Drug Conjugates Rdc Market Size by Country in 2024
Figure 55. Germany Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radionuclide Drug Conjugates Rdc Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Radionuclide Drug Conjugates Rdc Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radionuclide Drug Conjugates Rdc Market Size by Region in 2024
Figure 68. China Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radionuclide Drug Conjugates Rdc Sales and Growth Rate (K Units)
Figure 79. South America Radionuclide Drug Conjugates Rdc Sales Market Share by Country in 2024
Figure 80. South America Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (M USD)
Figure 81. South America Radionuclide Drug Conjugates Rdc Market Size by Country in 2024
Figure 82. Brazil Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size by Region in 2024
Figure 92. Saudi Arabia Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radionuclide Drug Conjugates Rdc Production Market Share by Region (2020-2025)
Figure 103. North America Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 106. China Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Radionuclide Drug Conjugates Rdc Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Radionuclide Drug Conjugates Rdc Market Share Forecast by Type (2026-2035)
Figure 111. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Application (2026-2035)
Figure 112. Global Radionuclide Drug Conjugates Rdc Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Radionuclide Drug Conjugates Rdc
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radionuclide Drug Conjugates Rdc Market Size (M USD), 2025-2035
Figure 5. Global Radionuclide Drug Conjugates Rdc Market Size (M USD) (2020-2035)
Figure 6. Global Radionuclide Drug Conjugates Rdc Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radionuclide Drug Conjugates Rdc Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Radionuclide Drug Conjugates Rdc Product Life Cycle
Figure 13. Radionuclide Drug Conjugates Rdc Sales Share by Manufacturers in 2025
Figure 14. Global Radionuclide Drug Conjugates Rdc Revenue Share by Manufacturers in 2025
Figure 15. Radionuclide Drug Conjugates Rdc Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Radionuclide Drug Conjugates Rdc Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Radionuclide Drug Conjugates Rdc Revenue in 2025
Figure 18. Industry Chain Map of Radionuclide Drug Conjugates Rdc
Figure 19. Global Radionuclide Drug Conjugates Rdc Market PEST Analysis
Figure 20. Global Radionuclide Drug Conjugates Rdc Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Radionuclide Drug Conjugates Rdc Market Share by Type
Figure 27. Sales Market Share of Radionuclide Drug Conjugates Rdc by Type (2020-2025)
Figure 28. Sales Market Share of Radionuclide Drug Conjugates Rdc by Type in 2025
Figure 29. Market Share of Radionuclide Drug Conjugates Rdc by Type (2020-2025)
Figure 30. Market Share of Radionuclide Drug Conjugates Rdc by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Radionuclide Drug Conjugates Rdc Market Share by Application
Figure 33. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Application (2020-2025)
Figure 34. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Application in 2025
Figure 35. Global Radionuclide Drug Conjugates Rdc Market Share by Application (2020-2025)
Figure 36. Global Radionuclide Drug Conjugates Rdc Market Share by Application in 2025
Figure 37. Global Radionuclide Drug Conjugates Rdc Sales Growth Rate by Application (2020-2025)
Figure 38. Global Radionuclide Drug Conjugates Rdc Sales Market Share by Region (2020-2025)
Figure 39. Global Radionuclide Drug Conjugates Rdc Market Size by Region (2020-2025)
Figure 40. North America Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Radionuclide Drug Conjugates Rdc Sales Market Share by Country in 2024
Figure 43. North America Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Radionuclide Drug Conjugates Rdc Market Size by Country in 2024
Figure 45. U.S. Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Radionuclide Drug Conjugates Rdc Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Radionuclide Drug Conjugates Rdc Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Radionuclide Drug Conjugates Rdc Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Radionuclide Drug Conjugates Rdc Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Radionuclide Drug Conjugates Rdc Sales Market Share by Country in 2024
Figure 53. Europe Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Radionuclide Drug Conjugates Rdc Market Size by Country in 2024
Figure 55. Germany Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Radionuclide Drug Conjugates Rdc Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Radionuclide Drug Conjugates Rdc Sales Market Share by Region in 2024
Figure 67. Asia Pacific Radionuclide Drug Conjugates Rdc Market Size by Region in 2024
Figure 68. China Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Radionuclide Drug Conjugates Rdc Sales and Growth Rate (K Units)
Figure 79. South America Radionuclide Drug Conjugates Rdc Sales Market Share by Country in 2024
Figure 80. South America Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (M USD)
Figure 81. South America Radionuclide Drug Conjugates Rdc Market Size by Country in 2024
Figure 82. Brazil Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Radionuclide Drug Conjugates Rdc Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Radionuclide Drug Conjugates Rdc Market Size by Region in 2024
Figure 92. Saudi Arabia Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Radionuclide Drug Conjugates Rdc Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Radionuclide Drug Conjugates Rdc Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Radionuclide Drug Conjugates Rdc Production Market Share by Region (2020-2025)
Figure 103. North America Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 106. China Radionuclide Drug Conjugates Rdc Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Radionuclide Drug Conjugates Rdc Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Radionuclide Drug Conjugates Rdc Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Radionuclide Drug Conjugates Rdc Market Share Forecast by Type (2026-2035)
Figure 111. Global Radionuclide Drug Conjugates Rdc Sales Forecast by Application (2026-2035)
Figure 112. Global Radionuclide Drug Conjugates Rdc Market Share Forecast by Application (2026-2035)
